European Archives - Page 551 of 1052 - European Medical Journal

EMJ Oncology 8.1 2020 Feature Image

Breast Cancer in Young Females: Real-World Data to Fill the Gap

Breast cancer (BC) is the most common cause of cancer-related deaths in females under 45 years…

EMJ Oncology 8.1 2020 Feature Image

EMJ Oncology 8.1 2020

EMJ Oncology shares an impressive collection of new and interesting research, alongside our independent review of European Society for Medical Oncology (ESMO) Virtual Congress 2020 with research and breaking news from the virtual event.

EMJ Oncology 8.1 2020 Feature Image

COVID-19: Impact on Cancer Patients and Oncology Professionals

TRANSFORMATIVE is a term that appropriately describes the striking developments made in the oncology field in recent years. Yet again the…

EMJ Oncology 8.1 2020 Feature Image

Trends in Breast Cancer Mortality Between 2001 and 2017: An Observational Study in Europe and the UK

The global incidence of breast cancer was 1.96 million cases in 2017, making it the third highest incident cancer…

EMJ Oncology 8.1 2020 Feature Image

Next-Generation Sequencing Standard of Care for Molecular Profiling

Given that COVID-19 has posed unique challenges in cancer care, a number of speakers addressed, with evidence, the impact of COVID-19…

EMJ Oncology 8.1 2020 Feature Image

Identifying the Best Ki67 Cut-Off for Determining Luminal Breast Cancer Subtypes Using Immunohistochemical Analysis and PAM50 Genomic Classification

Gene expression profiling has a significant impact on understanding the biology of breast cancer (BC)…

Oncogenic Drivers in Advanced NSCLC: Navigating an Evolving Landscape to Optimise Patient Outcomes

The oncology community has been experiencing an unprecedented moment in lung cancer diagnosis and treatment; however, despite significant…

EMJ Oncology 8.1 2020 Feature Image

Prognostic Value of Compartmental Spatial Analysis of Tumour-Infiltrating Lymphocytes in Triple-Negative Breast Cancer

Analyses on tumour-infiltrating lymphocytes (TIL) to date have mainly evaluated stromal TIL and possibly intratumoural TIL…

Congress Interview Professor John B.A.G. Haanen

ESMO Congress Interview: Professor John B.A.G. Haanen

You have an impressive scientific background, completing a scientific PhD in immunohaematology in addition to your clinical training…

EMJ Oncology 8.1 2020 Feature Image

Long-term Survival Following Photodynamic Therapy for Glioma Depending on MGMT

The gross total resection of a glial tumour is the aim of complex treatment and gives greater efficiency of the subsequent treatment stages, defining patients’ longevity…